Detection of (1, 3)-β-d-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts
- 1 September 2012
- journal article
- research article
- Published by Springer Nature in Mycopathologia
- Vol. 175 (1-2) , 33-41
Abstract
The incidence of invasive fungal infections (IFI) has increased in recent years, especially among immunocompromised hosts (ICH). In 2003, the Fungitell® assay received FDA clearance for the presumptive diagnosis of IFI using serum and detects (1-3)-β-d-glucan, which is a major cell wall component of certain fungi (e.g., Candida, Aspergillus, and Pneumocystis). The goal of the current study was to assess the performance of the assay on bronchoalveolar lavage (BAL) fluid and serum to identify IFI in ICH. Patients were classified as having proven, probable, possible, or no IFI according to the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) guidelines. Among 109 patients for whom the results of Fungitell were compared to the EORTC/MSG criteria, Fungitell showed a low positive predictive value for the identification of IFI from both BAL (20.0 %) and serum (26.7 %). However, the negative predictive value of Fungitell was significantly higher for both sample types (BAL, 83.0 %; serum, 84.8 %). Interestingly, the results of Fungitell were positive in BAL and serum in 7/8 (87.5 %) patients diagnosed with Pneumocystis pneumonia (PcP) by real-time, non-nested PCR. These data indicate that the Fungitell assay has a low positive predictive value for the diagnosis of IFI in ICH, regardless of the specimen type that is tested. However, testing of serum samples by Fungitell may permit a rapid and noninvasive initial screening approach in patients with presumed PcP.Keywords
This publication has 34 references indexed in Scilit:
- -Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)Clinical Infectious Diseases, 2011
- Blood (1->3)- -D-Glucan as a Diagnostic Test for HIV-Related Pneumocystis jirovecii PneumoniaClinical Infectious Diseases, 2011
- Serum (1→3)-β- d -Glucan Levels in Primary Infection and Pulmonary Colonization with Pneumocystis jiroveciiJournal of Clinical Microbiology, 2011
- Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificityDiagnostic Microbiology and Infectious Disease, 2011
- Emerging opportunistic yeast infectionsThe Lancet Infectious Diseases, 2011
- UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONSMediterranean Journal of Hematology and Infectious Diseases, 2011
- Serum (1-3)-β- d -Glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological MalignancyJournal of Clinical Microbiology, 2009
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- Diagnostic value of DNA, (1-3)-β-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreusDiagnostic Microbiology and Infectious Disease, 2007
- A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluidDiagnostic Microbiology and Infectious Disease, 2006